Researchers have made advancements in car-t cell design, which may help overcome solid tumor defenses. Engineered cells, including gamma-delta t cells, are being explored as a potential treatment for various types of solid tumors, such as bowel and brain cancer. The new approach appears to show promise in shrinking tumors that are resistant to treatment.